Try Fund Library Premium
For Free with a 30 day trial!
U.S. Equity
Click for more information on Fundata’s FundGrade
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
2024, 2023, 2022, 2021, 2020
Click for more information on Fundata’s FundGrade
|
NAVPS (04-04-2025) |
$44.49 |
|---|---|
| Change |
-$2.23
(-4.76%)
|
As at February 28, 2025
As at January 31, 2025
As at December 31, 2024
Loading...
Inception Return (July 31, 1995): 8.31%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.51% | 1.95% | 9.90% | -0.31% | 21.12% | 33.62% | 18.15% | 15.75% | 18.98% | 18.43% | 16.85% | 17.48% | 17.89% | 15.25% |
| Benchmark | -1.62% | 2.05% | 13.55% | 1.79% | 25.98% | 28.01% | 17.48% | 17.23% | 18.56% | 17.15% | 15.74% | 15.38% | 16.17% | 14.61% |
| Category Average | -2.55% | -0.30% | 8.98% | 1.42% | 18.49% | 21.72% | 12.57% | 12.21% | 14.32% | 12.93% | 11.60% | 11.56% | 12.43% | 10.56% |
| Category Rank | 908 / 1,336 | 330 / 1,327 | 742 / 1,318 | 1,069 / 1,328 | 593 / 1,292 | 108 / 1,210 | 127 / 1,141 | 210 / 1,086 | 65 / 1,023 | 43 / 955 | 44 / 868 | 51 / 794 | 38 / 701 | 45 / 650 |
| Quartile Ranking | 3 | 1 | 3 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Return % | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 1.83% | -3.18% | 5.39% | 7.16% | -1.22% | 0.19% | 1.64% | 1.85% | 4.13% | 2.27% | 3.31% | -3.51% |
| Benchmark | 3.07% | -2.70% | 4.13% | 3.97% | 2.12% | 0.07% | 2.23% | 2.12% | 6.59% | 0.26% | 3.46% | -1.62% |
37.88% (February 2000)
-21.85% (February 2001)
| Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 21.81% | -0.84% | 22.08% | 8.77% | 25.94% | 29.23% | 24.97% | -22.89% | 37.42% | 37.19% |
| Benchmark | 20.77% | 8.65% | 13.80% | 3.98% | 25.18% | 16.07% | 28.16% | -12.52% | 23.32% | 36.01% |
| Category Average | 10.40% | 6.16% | 13.43% | -2.19% | 22.72% | 13.97% | 23.22% | -14.41% | 18.85% | 26.98% |
| Quartile Ranking | 1 | 4 | 1 | 1 | 2 | 1 | 2 | 4 | 1 | 1 |
| Category Rank | 84/ 645 | 599/ 693 | 109/ 770 | 90/ 856 | 305/ 928 | 138/ 1,004 | 433/ 1,069 | 903/ 1,124 | 107/ 1,187 | 234/ 1,283 |
37.42% (2023)
-22.89% (2022)
| Name | Percent |
|---|---|
| US Equity | 92.24 |
| International Equity | 3.79 |
| Cash and Equivalents | 3.44 |
| Canadian Equity | 0.54 |
| Foreign Corporate Bonds | 0.01 |
| Other | -0.02 |
| Name | Percent |
|---|---|
| Technology | 70.27 |
| Healthcare | 18.01 |
| Cash and Cash Equivalent | 3.44 |
| Consumer Services | 2.79 |
| Financial Services | 2.26 |
| Other | 3.23 |
| Name | Percent |
|---|---|
| North America | 96.23 |
| Europe | 3.16 |
| Latin America | 0.47 |
| Asia | 0.15 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| NVIDIA Corp | 10.25 |
| Apple Inc | 9.66 |
| Microsoft Corp | 9.51 |
| Alphabet Inc Cl A | 8.08 |
| Meta Platforms Inc Cl A | 5.54 |
| Broadcom Inc | 3.86 |
| Eli Lilly and Co | 2.46 |
| UnitedHealth Group Inc | 2.16 |
| Salesforce Inc | 1.67 |
| Netflix Inc | 1.58 |
RBC Life Science and Technology Fund Series A
Median
Other - U.S. Equity
| Standard Deviation | 15.18% | 15.56% | 15.11% |
|---|---|---|---|
| Beta | 1.01% | 1.03% | 1.08% |
| Alpha | 0.01% | 0.00% | 0.00% |
| Rsquared | 0.82% | 0.84% | 0.84% |
| Sharpe | 0.93% | 1.05% | 0.91% |
| Sortino | 1.63% | 1.71% | 1.33% |
| Treynor | 0.14% | 0.16% | 0.13% |
| Tax Efficiency | 100.00% | 100.00% | 100.00% |
| Volatility |
|
|
|
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 11.15% | 15.18% | 15.56% | 15.11% |
| Beta | 1.01% | 1.01% | 1.03% | 1.08% |
| Alpha | -0.04% | 0.01% | 0.00% | 0.00% |
| Rsquared | 0.67% | 0.82% | 0.84% | 0.84% |
| Sharpe | 1.42% | 0.93% | 1.05% | 0.91% |
| Sortino | 3.19% | 1.63% | 1.71% | 1.33% |
| Treynor | 0.16% | 0.14% | 0.16% | 0.13% |
| Tax Efficiency | 100.00% | 100.00% | 100.00% | 100.00% |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | July 31, 1995 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | $2,466 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| RBF274 |
The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.
The fund’s investment process is primarily based on fundamental research, although the portfolio manager will also consider quantitative and technical factors. Stock selection decisions are ultimately based on an understanding of the company, its business and its outlook. Life science investments include biotechnology, medical devices and services, pharmaceuticals and medical instruments.
| Portfolio Manager |
RBC Global Asset Management Inc.
|
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
RBC Global Asset Management Inc. |
|---|---|
| Custodian |
RBC Investor Services Trust (Canada) |
| Registrar |
RBC Global Asset Management Inc. Royal Bank of Canada RBC Investor Services Trust (Canada) |
| Distributor |
Royal Mutual Funds Inc. |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 25 |
| PAC Subsequent | 25 |
| SWP Allowed | Yes |
| SWP Min Balance | 10,000 |
| SWP Min Withdrawal | 100 |
| MER | 2.05% |
|---|---|
| Management Fee | 1.75% |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 1.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!
Fund Library
